Proposed Directors of Tirupati Graphite explain why they have requisitioned an GM. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDNL.L Share News (DNL)

  • There is currently no data for DNL

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

IP Group Says 2015 Was Likely Its Best Ever Financial Showing

Tue, 12th Jan 2016 07:47

LONDON (Alliance News) - IP Group PLC, which works with university partners to commercialise scientific research, on Tuesday said it now expects that 2015 was its most successful year in terms of financial performance since its formation.

The group said it was boosted by a flurry of activity across its portfolio in the second half of 2015, including the admission of Diurnal Group PLC to AIM in December and fundraisings by listed portfolio companies Xeros Technology Group PLC, hVIVO PLC and Applied Graphene Materials PCL.

There also were moves to raise money by First Light Fusion Ltd and Ultrahaptics Ltd, two of its unquoted companies.

IP Group said it now expects the fair value of its portfolio to exceed GBP550.0 million as of December 31, 2015, a jump from the GBP350.0 million recorded one year earlier.

During 2015, the group provided GBP76.0 million of capital to its portfolio companies and a further GBP40.0 million strategic investment into Oxford Science Innovations PLC.

IP Group had gross cash and equivalents of more than GBP175.0 million at the end of 2015, up from GP97.0 million one year earlier.

By Samuel Agini; samagini@alliancenews.com; @samuelagini

Copyright 2016 Alliance News Ltd. All Rights Reserved.

More News
21 Apr 2021 17:59

TRADING UPDATES: Diurnal taps GBP20 million; Victoria buys new assets

TRADING UPDATES: Diurnal taps GBP20 million; Victoria buys new assets

Read more
15 Apr 2021 19:37

TRADING UPDATES: HSBC announces redemption of US dollar securities

TRADING UPDATES: HSBC announces redemption of US dollar securities

Read more
26 Mar 2021 14:36

TRADING UPDATES: Renew to buy J Browne; Idox in good start to year

TRADING UPDATES: Renew to buy J Browne; Idox in good start to year

Read more
23 Feb 2021 16:23

Alkindi sales drive revenue higher for Diurnal

(Sharecast News) - Speciality pharmaceuticals company Diurnal reported 6% growth in first-half total revenue in its interim results on Tuesday, to £1.21m.

Read more
23 Feb 2021 12:28

UPDATE: Diurnal Loss Widens In First Half; Signs Chronocort Deal

UPDATE: Diurnal Loss Widens In First Half; Signs Chronocort Deal

Read more
23 Feb 2021 12:15

Diurnal Reports Widened Loss In First Half Despite Revenue Growth

Diurnal Reports Widened Loss In First Half Despite Revenue Growth

Read more
16 Feb 2021 15:58

UK Earnings, Trading Statements Calendar - Next 7 Days

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
27 Jan 2021 09:22

Diurnal Inks Licence Agreement For Alkindi With Citrine Medicine

Diurnal Inks Licence Agreement For Alkindi With Citrine Medicine

Read more
14 Jan 2021 19:15

UK TRADING UPDATE SUMMARY: DWF Sets Up New Global Operating Structure

UK TRADING UPDATE SUMMARY: DWF Sets Up New Global Operating Structure

Read more
14 Jan 2021 15:18

IN BRIEF: Diurnal Pleased With Alkindi Sales In First Half

IN BRIEF: Diurnal Pleased With Alkindi Sales In First Half

Read more
13 Jan 2021 14:36

IN BRIEF: Diurnal Inks Turkey Distribution Deal For Alkindi, Chronocort

IN BRIEF: Diurnal Inks Turkey Distribution Deal For Alkindi, Chronocort

Read more
12 Jan 2021 19:12

IN BRIEF: Diurnal Submits Application To UK Regulators For Chronocort

IN BRIEF: Diurnal Submits Application To UK Regulators For Chronocort

Read more
11 Jan 2021 13:22

IN BRIEF: Diurnal Inks European Patent For Chronocort

IN BRIEF: Diurnal Inks European Patent For Chronocort

Read more
20 Nov 2020 18:03

IN BRIEF: Diurnal Secures Grant Of European Patent For Alkindi

IN BRIEF: Diurnal Secures Grant Of European Patent For Alkindi

Read more
20 Nov 2020 12:04

Diurnal gets European patent for 'Alkindi'

(Sharecast News) - Speciality pharmaceutical company Diurnal Group announced the grant of a patent for 'Alkindi', or hydrocortisone granules in capsules for opening, by the European Patent Office on Friday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.